Assessment of Seroconversion to SARS-CoV-2 in Health Care Unitunit Personnel
https://doi.org/10.31631/2073-3046-2021-20-5-32-38
Abstract
Relevance. The novel coronavirus pandemic is a major burden on public health and healthcare professionals. The study of the prevalence of antibodies among medical workers provides an understanding of the potential risk of transmission of the infectious agent, the level of herd immunity, the introduction of specific immunization and risk stratification in various areas of professional activities.
The purpose of this study was to assess the level of specific antibodies to SARS-CoV-2 in the personnel of the medical and sanitary unit, providing the population with outpatient and inpatient medical care.
Materials and methods. A study to assess seroprevalence to the SARS-CoV-2 virus was carried out in the Omsk region from September 2020 to December 2020. The study included 2 groups of employees of continuously operating organizations – the main group – employees of the medical and sanitary unit of the city of Omsk (n = 631), the control group consisted of employees of two industrial enterprises in the city of Omsk (n = 1696). The level of class G immunoglobulins to the SARS-CoV-2 virus was determined by enzyme-linked immunosorbent assay.
Results. Among medical workers, the proportion of people with a positive reaction to IgG was 73.1% (n = 461; 95% CI 69.5–76.4%). In the control group, the proportion of those who were seropositive was 3.9 times less than that – 18.6% (n = 315; 95% CI 16.8–20.5). Significant differences in seroprevalence in men and women were revealed in medical workers (χ2 = 4.164; p = 0.0413). The highest proportion of seroconversion was found in nursing staff – 85,4% (95% CI 71.6 – 93.1), in doctors – 63.3% (95% CI 55.0–70.9). The highest rate of seroprevalence was found among hospital medical workers – 81.9%, the lowest among employees of the administrative and economic service – 51,8%.
Conclusions. The level of specific antibodies to SARS-CoV-2 among medical workers significantly exceeded that of other professional groups, and there was a high proportion of seroconversion among junior medical personnel and in-patient medical unit workers.
About the Authors
A. I. BlokhRussian Federation
Aleksey I. Blokh – Junior Researcher; Assistant of the Department of Epidemiology
Omsk
+7 (3812)65-06-54
I. I. Panyushkina
Russian Federation
Irina I. Panyushkina – head of the clinical diagnostic laboratory
Omsk
+7 (905) 923-61-52
P. O. Pakhtusova
Russian Federation
Polina O. Pakhtusova – 6th year student of the Faculty of Medicine
Omsk
+7 (913) 686-15-84
I. V. Sergeeva
Russian Federation
Irina V. Sergeeva – Head of the Department of the Arbitration Laboratory for HIV and Opportunistic Infections Diagnostics at the Siberian Federal District Center for AIDS Prevention and Control
Omsk
+7 (913) 969-78-77
L. I. Levahina
Russian Federation
Lidia I. Levahina – Head of the Department of Epidemiological Surveillance and Methodological Work
Omsk
+7 (960) 999-14-50
I. P. Burashnikova
Russian Federation
Irina P. Burashnikova – Cand. Sci. (Med.), Associate Professor of the Depart- ment of Public Health and Health Care
Omsk
+7 (3812) 65-03-88
N. G. Anpilova
Russian Federation
Natalya G. Anpilova – Cand. Sci. (Med.), Assistant of the Department of Public Health and Health Care
Omsk
+7 (3812) 650388
N. A. Penyevskaya
Russian Federation
Natalya A. Penyevskaya – Dr. Sci. (Med.), Professor; Deputy Director of the Institute for Research, Professor of the Department of Epidemiology
Omsk
+7 (3812) 60-62-81
O. A. Pasechnik
Russian Federation
Oksana A. Pasechnik – Dr. Sci. (Med.), Associate Professor, Head of the Department of Public Health and Health Care; Chief Researcher
Omsk
+7 (3812) 65-03-88
N. V. Rudakov
Russian Federation
Nikolai V. Rudakov – Dr. Sci. (Med.), Professor, Director; Head of the Department of Microbiology, Virology and Immunology
Omsk
+7 (3812) 65-16-33
References
1. World Health Organization: official site. Available at: https://www.who.int/ru. Accessed: 04 June 2021.
2. Сovid-19 coronavirus pandemic. Available at: https://www.worldometers.info/coronavirus/.
3. Wilson N., Norton A., Young F.P., et al. Airborne transmission of severe acute respiratory syndrome coronavirus‐2 to healthcare workers: a narrative review. Anaesthesia. 2020;75:1086–95. doi:10.1111/ anae.15093.
4. Noor M., Haq M., Haq N., Amin S., et al. Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2? Cureus. 2020; 12(11), e11389. doi.org/10.7759/cureus.11389.
5. Black J., Bailey C., Przewrocka J., et al. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet.2020;395(10234):1418–1420. https://doi.org/10.1016/S0140- 6736(20)30917-X.
6. QuJ., WuC., LiX., et al. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020;71(16):2255–2258. doi.org/10.1093/cid/ciaa489
7. Brown L.D., Cai T.T., DasGupta A. Interval Estimation for a Binomial Proportion. Statist. Sci. 2001.16(2):101–133. doi: 10.1214/ss/1009213286.
8. Blokh A.I., Penievskaya N.A., Rudakov N.V., et al. Epidemic potential of COVID-19 in Omsk region and assessment of the anti-epidemic measures. Fundamental and Clinical Medicine. 2020;5(3):8–17 (In Russ.). doi.org/10.23946/2500-0764-2020-5-3-8-17.
9. Borges V., Isidro J., Macedo F., et al.Nosocomial Outbreak of SARS-CoV-2 in a «Non-COVID-19» Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission. Viruses. 2021;13(4):604. doi.org/10.3390/v13040604.
10. Zheng L., Wang X., Zhou C., et al. Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: a cross-sectional study. Clin Infect Dis. 2020;71:2109–2113. doi: 10.1093/cid/ciaa588.
11. Hossain A., Nasrullah S.M., Tasnim Z., et al. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis. EClinicalMedicine. 2021; 33: 100770. doi.org/10.1016/j.eclinm.2021.100770.
12. Peckham H., de Gruijter N.M., RaineC., at al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature communications. 2020;11(1):6317. doi.org/10.1038/ s41467-020-19741-6.
13. Chou R., Dana T., Buckley D.I., et al. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review. Annals of internal medicine. 2020; 173(2): 120–136. doi. org/10.7326/M20-1632
14. Korth J., Wilde B., Dolff S.,at al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2020; 128: 104437. doi.org/10.1016/j.jcv.2020.104437
Review
For citations:
Blokh A.I., Panyushkina I.I., Pakhtusova P.O., Sergeeva I.V., Levahina L.I., Burashnikova I.P., Anpilova N.G., Penyevskaya N.A., Pasechnik O.A., Rudakov N.V. Assessment of Seroconversion to SARS-CoV-2 in Health Care Unitunit Personnel. Epidemiology and Vaccinal Prevention. 2021;20(5):32-38. (In Russ.) https://doi.org/10.31631/2073-3046-2021-20-5-32-38